Please use this identifier to cite or link to this item: https://doi.org/10.1093/jjco/hyw185
Title: A review of prognostic scores after liver resection in hepatocellular carcinoma: The MSKCC, SLICER and SSCLIP scores
Authors: Chan, E.E
Chow, P.K.-H 
Keywords: adult
aged
cancer prognosis
cancer recurrence
Child Pugh score
controlled study
demography
ethnicity
female
human
intermethod comparison
liver cell carcinoma
liver resection
major clinical study
male
Memorial Sloan Kettering Cancer Center Score
prognostic assessment
Review
scoring system
Singapore Liver Cancer Recurrence Score
SSCLIP scoring system
validation study
very elderly
Carcinoma, Hepatocellular
cohort analysis
Liver Neoplasms
liver resection
middle aged
mortality
pathology
prognosis
survival analysis
Adult
Aged
Aged, 80 and over
Carcinoma, Hepatocellular
Cohort Studies
Female
Hepatectomy
Humans
Liver Neoplasms
Male
Middle Aged
Prognosis
Survival Analysis
Issue Date: 2017
Publisher: Oxford University Press
Citation: Chan, E.E, Chow, P.K.-H (2017). A review of prognostic scores after liver resection in hepatocellular carcinoma: The MSKCC, SLICER and SSCLIP scores. Japanese Journal of Clinical Oncology 47 (4) : 287-293. ScholarBank@NUS Repository. https://doi.org/10.1093/jjco/hyw185
Rights: Attribution 4.0 International
Abstract: Predicting prognosis in hepatocellular carcinoma (HCC) aids clinical decision-making and stratifies patient follow-up plans. There are currently three prognostic scores specific to liver resection of HCC published in the literature: the MSKCC, SLICER and SSCLIP scores. In this review, we highlight the methodology employed in the construction of these scores and discuss the strengths and weaknesses of each. Current limitations to prognostic scores include the inability to differentiate between early and late recurrences of HCC, the failure to account for the impact of aetiology of HCC and the assumption that ethnicity has no impact on disease process. Further scientific discoveries in these areas will allow for improvement in prognostication. The SLICER score is currently the most comprehensive. External validation of each score in cohorts of patients with different baseline demographics and clinical characteristics will be required to examine their stability and reliability. © The Author 2017. Published by Oxford University Press.
Source Title: Japanese Journal of Clinical Oncology
URI: https://scholarbank.nus.edu.sg/handle/10635/179260
ISSN: 0368-2811
DOI: 10.1093/jjco/hyw185
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1093_jjco_hyw185.pdf385.3 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons